Arvinas Sets Annual Meeting, Details CEO Pay & Board Changes, Responds to Shareholder Feedback on Compensation

summarizeSummary

Arvinas filed its definitive proxy statement for the 2026 Annual Meeting, detailing board changes, new CEO compensation, and actions taken in response to shareholder feedback on executive pay, alongside significant potential dilution from equity plans.

check_boxKey Events

• Annual Meeting Scheduled with Key Proposals

  The 2026 Annual Meeting of Stockholders will be held on June 24, 2026, to vote on the election of two Class II directors, a non-binding advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor.

• Board Size Reduction and New CEO Nomination

  The board of directors will be reduced from nine to eight members as Sunil Agarwal, M.D., will not stand for re-election. Randy Teel, Ph.D., who was appointed President and CEO in February 2026, is nominated for election as a Class II director.

• Company Responds to Shareholder Feedback on Executive Compensation

  Following a 75% 'say-on-pay' support in 2025, the company reviewed and decreased the size of 2026 annual equity grants for senior executives, implemented workforce reductions, and completed a previously announced $91.9 million share repurchase program to align with shareholder interests.

• New CEO Compensation Details Disclosed

  Randy Teel, Ph.D., as the new President and CEO, will receive an annual base salary of $680,000 and was granted 218,691 stock options and 147,179 restricted stock units in February 2026.

auto_awesomeAnalysis

This definitive proxy statement outlines key proposals for Arvinas' 2026 Annual Meeting, including director elections, an advisory vote on executive compensation, and auditor ratification. Notably, the board size will be reduced from nine to eight members, and new CEO Randy Teel, Ph.D., is nominated for election. The company explicitly details its response to a 75% 'say-on-pay' vote in 2025, which included reviewing and decreasing the size of 2026 annual equity grants for senior executives, implementing workforce reductions, and completing a previously announced share repurchase program. These actions demonstrate a commitment to addressing shareholder concerns regarding executive compensation and overall performance. However, the significant potential dilution from approximately 9.72 million shares available for future issuance under equity compensation plans remains a long-term consideration for investors.